approval
saveSANDIMMUNE (CYCLOSPORINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 210d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 210d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 210d ago
- approvalCYCLOSPORINE — FDA approvalNov 28, 2025 · 308d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1100d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1100d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1100d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 16, 2022 · 1661d ago
same company · ±60 days · 6
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 6, 2004
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 6, 2004
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 6, 2004
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 6, 2004
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 6, 2004
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalDec 8, 2003
comments(0)
5-min edit window · permanent after that